Stocks and Investing Stocks and Investing
Thu, November 19, 2020

Brian Abrahams Maintained (BIIB) at Hold with Increased Target to $249 on, Nov 19th, 2020


Published on 2024-10-27 14:49:20 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $244 to $249 on, Nov 19th, 2020.

Brian has made no other calls on BIIB in the last 4 months.



There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 5 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Phil Nadeau of "Cowen & Co." Downgraded from Buy to Hold and Held Target at $215 on, Monday, November 9th, 2020
  • Colin Bristow of "UBS" Initiated at Hold and Held Target at $268 on, Wednesday, October 28th, 2020
  • Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $282 on, Tuesday, October 27th, 2020
  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $244 on, Thursday, October 22nd, 2020
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $265 on, Tuesday, October 20th, 2020


These are the ratings of the 6 analyists that currently disagree with Brian


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $289 on, Monday, November 9th, 2020
  • Geoff Meacham of "B of A Securities" Downgraded from Hold to Sell and Held Target at $240 on, Monday, November 9th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $382 on, Monday, November 9th, 2020
  • Steve Chesney of "Atlantic Equities" Downgraded from Hold to Sell and Held Target at $175 on, Monday, November 9th, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $350 on, Thursday, October 22nd, 2020
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $357 on, Thursday, October 22nd, 2020
Contributing Sources